|
[Related PubMed/MEDLINE] Total Number of Papers: 12526
|
|
|
[Display Entries]
|
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of
|
|
|
|
Abbreviation |
: HLA |
Long Form |
: human leukocyte antigen |
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2022 |
|
HN, HPIV3 |
2 |
2022 |
|
allo-HCT, MMUD, MSD, MUD, UCB |
3 |
2022 |
|
AA, ATG, HSCT, PBSC, PTCy |
4 |
2022 |
|
iSNVs |
5 |
2022 |
|
AFT, DCGF, EMM, TcEMM, WGCNA |
6 |
2022 |
|
ICIs, irAEs |
7 |
2022 |
|
APC, HNSCC, MHCII, PDAC, TCRs |
8 |
2022 |
|
anti-TPO antibodies, CTLA, GD, HT, TPO, TRAb, TRAb, TSGT |
9 |
2022 |
|
IL, NK, TCR-T |
10 |
2022 |
|
HIV |
11 |
2022 |
|
COVID-19, SARS-CoV-2 |
12 |
2022 |
|
allo-SCT, FDTCC, PTCy, RIC |
13 |
2022 |
|
Abs, DN, GSTT1 |
14 |
2022 |
|
CIN, LOH, LUSC, NSCLC, PD-L1, TMB, TME |
15 |
2022 |
|
ETUCAR-T, NK, TCR, UCAR-T |
16 |
2022 |
|
HIV-1, IMC, LucR, VIA |
17 |
2022 |
|
NGM |
18 |
2022 |
|
SARS-CoV-2 |
19 |
2022 |
|
iPSC, MHC |
20 |
2022 |
|
EVTs, GDM, IRS |
21 |
2022 |
|
IMIDs, RA, SLE, SSc |
22 |
2022 |
|
MHC, NGS |
23 |
2022 |
|
SCDI |
24 |
2022 |
|
haplo-SCT, QoL, SAA |
25 |
2022 |
|
uORFs, uPeptides |
26 |
2022 |
|
CHB, HIV, KIRs, NK |
27 |
2022 |
|
LN, PCR-SSP, SLE |
28 |
2022 |
|
AR, cPRA, MFI, RIS |
29 |
2022 |
|
MFI, PRA |
30 |
2022 |
|
MHC, non-V-SAT, SARS-CoV-2, SAT, V-SAT |
31 |
2022 |
|
PBMNC |
32 |
2022 |
|
CI, COVID-19, CT, OR, PCR |
33 |
2022 |
|
axSpA, CRP, TNFi |
34 |
2022 |
|
B-VSTs, GMP, HSCT, VSTS, VSTs |
35 |
2022 |
|
HBV, HCV, PBMCs, uPA |
36 |
2022 |
|
MD, RMSD, RMSF, WNV |
37 |
2022 |
|
APS, HT |
38 |
2022 |
|
IIM, MYOGEN, PM |
39 |
2022 |
3pHLA-score improves structure-based peptide-HLA binding affinity prediction. |
ML, pHLA |
40 |
2022 |
A carcinoembryonic antigen-specific cell therapy selectively targets tumor cells with HLA loss of heterozygosity in vitro and in vivo. |
CAR, CEA, LIR-1 |
41 |
2022 |
A Case of Methimazole-Induced Acute Pancreatitis With an HLA Allele Causing Antithyroid Drug-Induced Agranulocytosis. |
MIP, MMI, PTU |
42 |
2022 |
A case of successful desensitization using therapeutic plasma exchange in high-risk HLA incompatible kidney transplantation. |
CKD, MFI, SAB |
43 |
2022 |
A CD33 frameshift variant is associated with neuromyelitis optica spectrum disorders. |
AQP4-Ab, IL, NMOSD, WES |
44 |
2022 |
A clinician's guide to HLA matching in allogeneic hematopoietic stem cell transplant. |
HSCT |
45 |
2022 |
A comprehensive human leukocyte antigen analysis of 36 782 cord blood units stored in the Australian Public Cord Blood Banking Network. |
CBBs, CBU |
46 |
2022 |
A Computational Pipeline for Predicting Cancer Neoepitopes. |
MuPeXI |
47 |
2022 |
A genome-wide association study for rheumatoid arthritis replicates previous HLA and non-HLA associations in a cohort from South Africa. |
GWAS, RA, SEBSSAs |
48 |
2022 |
A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodies. |
AINS, GENERATE, GWAS, PRKCB |
49 |
2022 |
A longitudinal analysis of immune escapes from HLA-B*13-restricted T-cell responses at early stage of CRF01_AE subtype HIV-1 infection and implications for vaccine design. |
HIV-1, MSM |
50 |
2022 |
A national proficiency scheme for human leucocyte antigen typing by next-generation sequencing. |
HSCT, NGS, PT, SOT |
51 |
2022 |
A novel prognostic and therapeutic target biomarker based on necroptosis-related gene signature and immune microenvironment infiltration in gastric cancer. |
GC, GEO, MSI, NRG risk score, TMB |
52 |
2022 |
A Novel Proteogenomic Integration Strategy Expands the Breadth of Neo-Epitope Sources. |
--- |
53 |
2022 |
A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer. |
CMap, DEG, GDSC, GEO, GEPIA, HPA, OC, TMB, TMBrisk, WGCNA |
54 |
2022 |
A peptide-based vaccine ACP derived from antigens of Mycobacterium tuberculosis induced Th1 response but failed to enhance the protective efficacy of BCG in mice. |
BCG, CFUs, TB, Th1 |
55 |
2022 |
A Phase I Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients With Solid Tumor Malignancies. |
--- |
56 |
2022 |
A short HLA-DRA isoform binds the HLA-DR2 heterodimer on the outer domain of the peptide-binding site. |
APCs, sHLA-DRA |
57 |
2022 |
A short review on cervical cancer cell lines characterization and their corresponding human leukocyte antigen (HLA) type expression. |
--- |
58 |
2022 |
A Single-Center Experience on HLA Typing with 11 Loci Next Generation Sequencing in Korean Patients with Hematologic Disease. |
NGS |
59 |
2022 |
A Summary on the Genetics of Systemic Lupus Erythematosus, Rheumatoid Arthritis, Systemic Sclerosis, and Sjögren's Syndrome. |
IFN |
60 |
2022 |
A systematic review and meta-analysis of HLA class II associations in patients with IgG4 autoimmunity. |
IgG4-AID |
61 |
2022 |
A Systematic Review of T Cell Epitopes Defined from the Proteome of Hepatitis B Virus. |
HBV |
62 |
2022 |
ABO-adjusted calculated panel reactive antibody (cPRA): A unified metric for immunologic compatibility in kidney transplantation. |
cPRA |
63 |
2022 |
Acquired aplastic anemia complicated with anti-glomerular basement membrane disease successfully treated with immunosuppressive therapy: a case report. |
AA, anti-GBM disease, IST, MP, PSL |
64 |
2022 |
Acute Ischemic Stroke Due to Spontaneous Internal Carotid Artery Dissection in a Human Leukocyte Antigen (HLA) B27 Young Male. |
MRA, MRI, USG |
65 |
2022 |
Adaptive Immune Responses, Immune Escape and Immune-Mediated Pathogenesis during HDV Infection. |
HBV, HCV, HDV, HIV, IFN |
66 |
2022 |
Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors. |
ACT, TCR, TIL |
67 |
2022 |
Advances in the Pathomechanisms of Delayed Drug Hypersensitivity. |
TCR |
68 |
2022 |
Adverse effect of donor-specific anti-human leukocyte antigen (HLA) antibodies directed at HLA-DP/-DQ on engraftment in cord blood transplantation. |
CBT |
69 |
2022 |
Afucosylation of HLA-specific IgG1 as a potential predictor of antibody pathogenicity in kidney transplantation. |
AMR, DSAs, IgG, NK |
70 |
2022 |
Allele and Haplotype Frequencies of HLA-A, -B, -C, and -DRB1 Genes in 3,750 Cord Blood Units From a Kinh Vietnamese Population. |
PCR-SSO |
71 |
2022 |
Allele frequency and the associations of HLA-DRB1 and HLA-DQB1 polymorphisms with pemphigus subtypes and disease severity. |
HLA-DQB1, PF, PV |
72 |
2022 |
Allelic imbalance of HLA-B expression in human lung cells infected with coronavirus and other respiratory viruses. |
AE |
73 |
2022 |
Allelic variation in HLA-DRB1 is associated with development of antidrug antibodies in cancer patients treated with atezolizumab that are neutralizing in vitro. |
ADA, NAb, OR |
74 |
2022 |
Allogeneic Transplant and Gene Therapy: Evolving Toward a Cure. |
GVHD, HCT, SCD |
75 |
2022 |
Alloimmune Risk Stratification for Kidney Transplant Rejection. |
EMA |
76 |
2022 |
Alloimmunity to Class 2 Human Leucocyte Antigens May Reduce HIV-1 Acquisition - A Nested Case-Control Study in HIV-1 Serodiscordant Couples. |
HIV, HIV |
77 |
2022 |
Altered Fc glycosylation of anti-HLA alloantibodies in hemato-oncological patients receiving platelet transfusions. |
PR |
78 |
2022 |
An association between a positive direct antiglobulin test and HLA-DR12 in COVID-19. |
COVID-19, DAT, Rh |
79 |
2022 |
An autoencoder-based deep learning method for genotype imputation. |
AE, CR, DL, GWAS, IQS, LOS, SCDA, SEN |
80 |
2022 |
An autologous humanized patient-derived xenograft (PDX) model for evaluation of nivolumab immunotherapy in renal cell cancer: a case report. |
HSPCs, mRCC, NK, NSG, PDX, RCC |
81 |
2022 |
An extremes of phenotype approach confirms significant genetic heterogeneity in patients with ulcerative colitis. |
GWA, MRUC, non-MRUC, OR, UC |
82 |
2022 |
An immunogenetic investigation of 30 autoimmune and autoinflammatory diseases and their links to psychiatric disorders in a nationwide sample. |
AIIDs |
83 |
2022 |
Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer. |
HNC, HPV, Illumina, Inc, SNPs |
84 |
2022 |
Analysis of KIR gene variants in The Cancer Genome Atlas and UK Biobank using KIRCLE. |
KIR, NK |
85 |
2022 |
Analysis of temporal changes in HIV-1 CRF01_AE gag genetic variability and CD8 T-cell epitope evolution. |
CRF, CTL, HIV-1 |
86 |
2022 |
Antigen and Cell-Based Assays for the Detection of Non-HLA Antibodies. |
AECAs, AMBR, DSA |
87 |
2022 |
Appearance of Anti-MDA5 Antibody-Positive Dermatomyositis After COVID-19 Vaccination. |
COVID-19, GAD, MDA5 |
88 |
2022 |
Approach to Highly Sensitized Kidney Transplant Candidates and a Positive Crossmatch. |
--- |
89 |
2022 |
Assessing the Efficacy of Alkylating Agent Regimens in the Treatment of Infantile Malignant Osteopetrosis: Cyclophosphamide, Busulfan, or Thiotepa. |
Bu, CY, GVHD, THIO |
90 |
2022 |
Assessment of Human Leukocyte Antigen Differences between Smokers with Reinke's Edema and Those with Laryngeal Cancer. |
PCR-SSP, SCC |
91 |
2022 |
Assessment of human leukocyte antigen matching algorithm PIRCHE-II on liver transplantation outcomes. |
PIRCHE-II |
92 |
2022 |
Assessment of Patient-Specific Human Leukocyte Antigen Genomic Loss at Relapse After Antithymocyte Globulin-Based T-Cell-Replete Haploidentical Hematopoietic Stem Cell Transplant. |
ATG, HSCT, OR |
93 |
2022 |
Association between germ-line HLA and immune-related adverse events. |
HED, ICIs, irAEs |
94 |
2022 |
Association between HLA alleles and sub-phenotype of childhood steroid-sensitive nephrotic syndrome. |
SDNS/FRNS, SSNS, SSNSWR |
95 |
2022 |
Association between human leukocyte antigen class II (HLA-DRB and -DQB) alleles and outcome of exposure to Mycobacterium tuberculosis: a cross-sectional study in Nairobi, Kenya. |
IGRA, LTBI, PTB, TB |
96 |
2022 |
Association between Human Leukocyte Antigen Polymorphism and Human Papillomavirus Infection in Brazilian Women. |
HPV |
97 |
2022 |
Association between human leukocyte antigens and cutaneous adverse drug reactions to antiepileptics and antibiotics in the Iranian population. |
AGEP, cADRs, DRESS, SJS/TEN |
98 |
2022 |
Association of anti-SARS-COV-2 vaccine with increased incidence of myositis-related anti-RNA-synthetases auto-antibodies. |
--- |
99 |
2022 |
Association of end-stage renal disease with HLA phenotypes and panel reactive antibodies in patients awaiting renal transplantation in Hunan Province. |
ESRD, PRA |
100 |
2022 |
Association of HLA Alleles with Antiepileptic Drug-Induced Mild Cutaneous Reactions: A Case-Control Study of a Northeast Han Chinese Population. |
AEDs, cADRs, CBZ, LEV, MPE, OXC, SBT |
|